Masters of Clinical Research, Inc. | Augusta, GA

Research site

Location

1232 Augusta West Parkway, Augusta, Georgia, United States of America

Website

https://www.mastersofclinicalresearch.com/

Site insights

Top conditions

Top treatments

Tanezumab

Elagolix

Estradiol

Dexpramipexole

Norethindrone Acetate

Celecoxib

GFB-887

Empagliflozin

mRNA-1345

Tirzepatide

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Active trials

6 of 21 total trials

A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)

The main purpose of this study is to evaluate the safety and efficacy of donanemab in participants with preclinical Alzheimer's Disease (AD). Approxi...

Enrolling

Alzheimer Disease

Drug: Donanemab

Drug: Placebo

A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity (SURMOUNT-MMO)

This study will investigate the effect of tirzepatide on the reduction of morbidity and mortality in adults living with obesity and provide additiona...

Active, not recruiting

Overweight

Obesity

Drug: Placebo

Drug: Tirzepatide

A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma (EXHALE-4)

The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma to...

Active, not recruiting

Asthma Attack

Asthma; Eosinophilic

Drug: Dexpramipexole Dihydrochloride

Drug: Placebo

A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma. (EXHALE-2)

This study will assess the efficacy and safety of dexpramipexole as an adjunctive oral therapy in participants with inadequately controlled asthma wi...

Enrolling

Asthma

Asthma; Eosinophilic

Drug: Placebo

Drug: Dexpramipexole Dihydrochloride

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease

This study is open to adults with chronic kidney disease (CKD) that is at risk of getting worse. People who have taken a specific type of medication...

Enrolling

Chronic Kidney Disease

Drug: Vicadrostat

Drug: Empagliflozin

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) (MOVE-Lp(a))

The purpose of this study is to evaluate the efficacy of muvalaplin in reducing cardiovascular risk in participants with high lipoprotein(a) who have...

Enrolling

Atherosclerotic Cardiovascular Disease (ASCVD)

Elevated Lp(a)

Drug: Placebo

Drug: Muvalaplin